 |
Previous Article | Next Article 
The Journal of Neuroscience, January 1, 2001, 21(1):98-108
Vitamin D Hormone Confers Neuroprotection in Parallel with
Downregulation of L-Type Calcium Channel Expression in Hippocampal
Neurons
Lawrence D.
Brewer1,
Veronique
Thibault1,
Kuey-Chu
Chen1,
Moises C.
Langub2,
Philip W.
Landfield1, and
Nada M.
Porter1
Departments of 1 Pharmacology and
2 Internal Medicine, Division of Nephrology, Bone and
Mineral Metabolism, College of Medicine, University of Kentucky,
Lexington, Kentucky 40536
Although vitamin D hormone (VDH; 1,25-dihydroxyvitamin
D3), the active metabolite of vitamin D, is the
major Ca2+-regulatory steroid hormone in the
periphery, it is not known whether it also modulates
Ca2+ homeostasis in brain neurons. Recently, chronic
treatment with VDH was reported to protect brain neurons in both aging
and animal models of stroke. However, it is unclear whether those
actions were attributable to direct effects on brain cells or indirect effects mediated via peripheral pathways. VDH modulates L-type voltage-sensitive Ca2+ channels (L-VSCCs) in
peripheral tissues, and an increase in L-VSCCs appears linked to both
brain aging and neuronal vulnerability. Therefore, we tested the
hypothesis that VDH has direct neuroprotective actions and, in
parallel, targets L-VSCCs in hippocampal neurons.
Primary rat hippocampal cultures, treated for several days with VDH,
exhibited a U-shaped concentration-response curve for neuroprotection
against excitotoxic insults: lower concentrations of VDH (1-100
nM) were protective, but higher, nonphysiological concentrations (500-1000 nM) were not. Parallel studies
using patch-clamp techniques found a similar U-shaped curve in which L-VSCC current was reduced at lower VDH concentrations and increased at
higher (500 nM) concentrations. Real-time PCR studies
demonstrated that VDH monotonically downregulated mRNA expression for
the 1C and 1D pore-forming subunits of
L-VSCCs. However, 500 nM VDH also nonspecifically reduced a
range of other mRNA species. Thus, these studies provide the first
evidence of (1) direct neuroprotective actions of VDH at relatively low
concentrations, and (2) selective downregulation of L-VSCC expression
in brain neurons at the same, lower concentrations.
Key words:
vitamin D; excitotoxicity; calcium channels; L-type; patch clamp; cell culture; hippocampus; calcitriol
Copyright © 2001 Society for Neuroscience 0270-6474/01/21198-11$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
D. M Lee, A. Tajar, A. Ulubaev, N. Pendleton, T. W O'Neill, D. B O'Connor, G. Bartfai, S. Boonen, R. Bouillon, F. F Casanueva, et al.
Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men
J. Neurol. Neurosurg. Psychiatry,
July 1, 2009;
80(7):
722 - 729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Brewer, A. L. S. Dowling, M. A. Curran-Rauhut, P. W. Landfield, N. M. Porter, and E. M. Blalock
Estradiol Reverses a Calcium-Related Biomarker of Brain Aging in Female Rats
J. Neurosci.,
May 13, 2009;
29(19):
6058 - 6067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Morelli, R. Squecco, P. Failli, S. Filippi, L. Vignozzi, A. K. Chavalmane, B. Fibbi, R. Mancina, G. Luciani, M. Gacci, et al.
The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder
Am J Physiol Cell Physiol,
May 1, 2008;
294(5):
C1206 - C1214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. McCann and B. N. Ames
Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?
FASEB J,
April 1, 2008;
22(4):
982 - 1001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Norris, E. M. Blalock, O. Thibault, L. D. Brewer, G. V. Clodfelter, N. M. Porter, and P. W. Landfield
Electrophysiological Mechanisms of Delayed Excitotoxicity: Positive Feedback Loop Between NMDA Receptor Current and Depolarization-Mediated Glutamate Release
J Neurophysiol,
November 1, 2006;
96(5):
2488 - 2500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Bergh, Y. Shao, E. Puente, R. L. Duncan, and M. C. Farach-Carson
Osteoblast Ca2+ permeability and voltage-sensitive Ca2+ channel expression is temporally regulated by 1,25-dihydroxyvitamin D3
Am J Physiol Cell Physiol,
March 1, 2006;
290(3):
C822 - C831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Spach and C. E. Hayes
Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice
J. Immunol.,
September 15, 2005;
175(6):
4119 - 4126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Spach, L. B. Pedersen, F. E. Nashold, T. Kayo, B. S. Yandell, T. A. Prolla, and C. E. Hayes
Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis
Physiol Genomics,
July 8, 2004;
18(2):
141 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|